Sociedad Química y Minera de Chile (NYSE:SQM) Given New $39.00 Price Target at JPMorgan Chase & Co.

Sociedad Química y Minera de Chile (NYSE:SQM - Free Report) had its price objective cut by JPMorgan Chase & Co. from $44.00 to $39.00 in a research report report published on Thursday morning,Benzinga reports. They currently have a neutral rating on the basic materials company's stock.

Several other equities research analysts have also recently commented on SQM. BMO Capital Markets lowered their price target on Sociedad Química y Minera de Chile from $55.00 to $45.00 and set an "outperform" rating for the company in a research note on Thursday, May 29th. Scotiabank cut their target price on Sociedad Química y Minera de Chile from $50.00 to $45.00 and set a "sector outperform" rating on the stock in a report on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $41.14.

Sociedad Química y Minera de Chile Trading Down 1.9%

Shares of Sociedad Química y Minera de Chile stock traded down $0.66 on Thursday, reaching $33.34. 708,475 shares of the company were exchanged, compared to its average volume of 1,081,751. Sociedad Química y Minera de Chile has a fifty-two week low of $29.36 and a fifty-two week high of $45.89. The firm has a market capitalization of $9.52 billion, a price-to-earnings ratio of -30.04, a price-to-earnings-growth ratio of 5.00 and a beta of 1.04. The company has a current ratio of 2.94, a quick ratio of 2.05 and a debt-to-equity ratio of 0.74. The stock has a fifty day moving average price of $33.88 and a 200-day moving average price of $37.50.

Sociedad Química y Minera de Chile (NYSE:SQM - Get Free Report) last released its earnings results on Wednesday, May 28th. The basic materials company reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.63 by ($0.15). Sociedad Química y Minera de Chile had a negative net margin of 6.74% and a positive return on equity of 16.12%. The business had revenue of $1.04 billion for the quarter, compared to analysts' expectations of $1.05 billion. During the same period last year, the firm earned ($3.04) EPS. The company's revenue was down 4.4% compared to the same quarter last year. On average, analysts expect that Sociedad Química y Minera de Chile will post -1.31 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of SQM. Brooklyn Investment Group lifted its holdings in shares of Sociedad Química y Minera de Chile by 61,700.0% during the first quarter. Brooklyn Investment Group now owns 618 shares of the basic materials company's stock worth $25,000 after buying an additional 617 shares during the last quarter. Banque Cantonale Vaudoise acquired a new position in Sociedad Química y Minera de Chile during the 1st quarter valued at $34,000. Kestra Investment Management LLC bought a new stake in Sociedad Química y Minera de Chile in the 4th quarter valued at $39,000. Jones Financial Companies Lllp boosted its holdings in Sociedad Química y Minera de Chile by 803.4% in the 4th quarter. Jones Financial Companies Lllp now owns 1,075 shares of the basic materials company's stock valued at $39,000 after purchasing an additional 956 shares during the period. Finally, Grove Bank & Trust acquired a new stake in Sociedad Química y Minera de Chile in the 1st quarter worth $46,000. Institutional investors and hedge funds own 12.41% of the company's stock.

About Sociedad Química y Minera de Chile

Sociedad Química y Minera de Chile SA operates as a mining company worldwide. The company offers specialty plant nutrients, including sodium potassium nitrate, specialty blends, and other specialty fertilizers under Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, ProP, and Prohydric brands. It also provides iodine and its derivatives for use in medical, agricultural, industrial, and human and animal nutrition products comprising x-ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical intermediates, polarizing films for LCD and LED screens, chemicals, organic compounds, and pigments, as well as added to edible salt to prevent iodine deficiency disorders.